CD90在肝内胆管细胞癌中的表达及其与患者预后不良的关系

朱彤; 饶井芬; 刘承一; 肇爽; 张力

doi:10.3969/j.issn.1001-5256.2020.02.024

CD90在肝内胆管细胞癌中的表达及其与患者预后不良的关系

DOI: 10.3969/j.issn.1001-5256.2020.02.024

1. 承德医学院附属医院肿瘤科
2. 承德医学院

基金项目:

承德市科学技术研究与发展计划项目(201706A039)；

详细信息

中图分类号: R735.7
计量
- 文章访问数: 880
- HTML全文浏览量: 30
- PDF下载量: 167
- 被引次数: 0
出版历程
- 收稿日期: 2019-10-24
- 出版日期: 2020-02-20

Expression of CD90 in intrahepatic cholangiocellular carcinoma and its association with poor prognosis

Department of Oncology,The Affiliated Hospital of Chengde Medical College

Research funding:

摘要

摘要:
目的探讨分析CD90在人肝内胆管细胞癌中的表达及与淋巴结转移和预后不良的关系。方法收集2013年3月-2016年3月承德医学院附属医院手术切除的肝内胆管细胞癌组织标本49例及其癌旁正常组织49例,另选取40例正常肝组织作为对照。采用免疫组化法检测所有标本CD90表达情况,并分析肝内胆管细胞癌患者CD90表达与临床指标、生存预后的关系。计量资料2组间比较采用t检验;计数资料2组间比较采用χ2检验,3组间比较及进一步两两比较均采用Kruskal-Wallis H检验。采用Kaplan-Meier曲线分析术后复发及生存情况,并应用log-rank检验进行比较。结果肝内胆管细胞癌组织CD90中强度阳性表达率为65. 31%,癌旁正常组织CD90中强度阳性表达率为30. 61%,正常肝组织CD90中强度阳性表达率为0,肝内胆管细胞癌组织中CD90蛋白中强度阳性表达率显著高于癌旁正常组织与正常肝组织（P值均<0. 05）。CD90蛋白表达与肝内胆管细胞癌患者TNM分期及肝门淋巴结转移有关（χ2值分别为12. 837、17. 824,P值均<0. 001）。CD90蛋白阴性/弱阳性表达患...
- 胆管上皮癌 /
- 抗原,Thy-1 /
- 预后
Abstract:
Objective To investigate the expression of CD90 in human intrahepatic cholangiocellular carcinoma and its association with lymph node metastasis and poor prognosis. Methods A total of 49 samples of intrahepatic cholangiocellular carcinoma tissue and 49 samples of adjacent tissue were collected after surgical resection in The Affiliated Hospital of Chengde Medical College from March 2013 to March2016,and 40 normal liver tissue samples were selected as control. Immunohistochemistry was used to measure the expression of CD90 in each sample,and its association with clinical indices,survival,and prognosis of patients with intrahepatic cholangiocellular carcinoma was analyzed. The t-test was used for comparison of continuous data between two groups; the chi-square test was used for comparison of categorical data between two groups,the Kruskal-Wallis H test was used for comparison between three groups and further comparison between two groups. The Kaplan-Meier curve was used to analyze postoperative recurrence and survival,and the log-rank test was used for comparison. Results The moderately positive expression rate of CD90 was 65. 31% in intrahepatic cholangiocellular carcinoma tissue,30. 61%in adjacent normal tissue,and 0% in normal liver tissue,suggesting that the intrahepatic cholangiocellular carcinoma tissue had a significantly higher moderately positive expression rate of CD90 than adjacent normal tissue and normal liver tissue( P < 0. 05). The expression of CD90 was associated with TNM stage and hilar lymph node metastasis in the patients with intrahepatic cholangiocellular carcinoma( χ2=12. 837 and 17. 824,both P < 0. 001). The patients with negative/weakly positive expression of CD90 had significantly higher relapse-free survival rate and overall survival rate after surgery than those with moderately/strongly positive expression( χ2= 3. 845 and 4. 152,P =0. 025 and 0. 021). Conclusion CD90 is highly expressed in human intrahepatic cholangiocellular carcinoma tissue,which is associated with hilar lymph node metastasis and poor prognosis and plays an important role in tumor development,progression,and metastasis.
- cholangiocarcinoma /
- antigens,Thy-1 /
- prognosis

HTML全文

参考文献(21)

[1] SHEN F,ZHANG H,YANG T,et al. The comprehensive surgical management for intrahepatic cholangiocarcinoma[J].Chin J Dig Surg,2018,17(3):213-218.(in Chinese)沈锋，张汉，杨田，等．肝内胆管癌的外科综合治疗[J]．中华消化外科杂志，2018,17(3):213-218.

[2] ZHANG K,CHE S,PAN C,et al. The SHH/Gli axis regulates CD90-mediated liver cancer stem cell function by activating the IL6/JAK2 pathway[J]. J Cell Mol Med,2018,22(7):3679-3690.

[3] YANG J,CAO Y,JIANG Y,et al. Relationship between expression of CD44,CD90 and prognosis of liver transplantation for hepatocellular carcinoma[J]. Mod Oncol,2017,25(19):3089-3094.(in Chinese)杨杰，曹毅，江艺，等．CD44,CD90的表达与肝癌肝移植术后复发转移的关系[J]．现代肿瘤医学，2017,25(19):3089-3094.

[4] DONG W,LIU L,CHEN Y,et al. The expressions and clinical significance of Ezrin and PTEN protein in intrahepatic cholangiocarcinoma[J]. Chin J Hepatobiliary Surg,2018,24(8):537-541.(in Chinese)董伟，刘路，陈赢，等．肝内胆管细胞癌中Ezrin和PTEN蛋白的表达及其临床意义[J]．中华肝胆外科杂志，2018,24(8):537-541.

[5] SUN L,GUO C,BURNETT J,et al. Association between expression of Carboxypeptidase 4 and stem cell markers and their clinical significance in liver cancer development[J]. J Cancer,2017,8(1):111-116.

[6] TANG ZH,TANG CW,WANG SH,et al. The research situation and progress in the invasion and metastasis mechanism of intrahepatic cholangiocarcinoma[J]. Chin J Dig Surg,2019,18(4):321-327.(in Chinese)汤朝晖，唐陈伟，王寿华，等．肝内胆管癌侵袭转移机制的研究现状与进展[J]．中华消化外科杂志，2019,18(4):321-327.

[7] SONG ZC,GUO CL,TANG JH,et al. Effect of PRR11 on the prognosis of patients with intrahepatic cholangiocarcinoma[J]. Chin J Gastroenterol Hepatol,2018,27(4):409-412.(in Chinese)宋宗昌，郭春亮，唐家宏，等．PRR11对肝内胆管细胞癌患者预后的影响[J]．胃肠病学和肝病学杂志，2018,27(4):409-412.

[8] LIU Q,CHEN K,LIU Z,et al. BORIS up-regulates OCT4 via histone methylation to promote cancer stem cell-like properties in human liver cancer cells[J]. Cancer Lett,2017,403:165-174.

[9] SHAO YM,ZHANG Y,YIN X,et al. Value of Sal-like 4 in the diagnosis and treatment of primary liver cancer[J]. J Clin Hepatol,2019,35(10):2320-2323.(in Chinese)邵玥明，张雨，殷鑫，等．SALL4在原发性肝癌诊治中的价值[J]．临床肝胆病杂志，2019,35(10):2320-2323.

[10] GAO SH,GAN HY,WANG J. Establishment of Nomogram model of postoperative recurrence of primary hepatocellular carcinoma with reference to inflammatory cytokines[J]. J Clin Hepatol,2019,35(7):1520-1524.(in Chinese)高素华，甘洪颖，王君．结合炎性细胞因子构建原发性肝癌术后复发的Nomogram模型[J]．临床肝胆病杂志，2019,35(7):1520-1524.

[11] TIAN YH,DU YC,HE YH,et al. The effect of CDCA5 on the prognosis and growth promoting in hepatocellular carcinoma[J]. Med J West China,2019,31(7):1014-1020.(in Chinese)田云鸿，杜毅超，何云洪，等．CDCA5对肝癌患者预后的影响及机制研究[J]．西部医学，2019,31(7):1014-1020.

[12] SU BW,BAI MH,LIU HC. Expression and significance of Fascin-1 in intrahepatic cholangiocarcinoma[J]. Guangdong Med J,2019,40(8):1091-1094.(in Chinese)苏宝威，白明辉，刘海潮．Fascin-1在肝内胆管细胞癌中的表达及意义[J]．广东医学，2019,40(8):1091-1094.

[13] LI J,HH SB,WANG LY,et al. Autophagy-dependent generation of Axin2+cancer stem-like cells promotes hepatocarcinogenesis in liver cirrhosis[J]. Oncogene,2017,36(48):6725-6737.

[14] WANG C,WU H,LIU Y,et al. Expression features and prognostic significance of Yes-associated protein in hepatocellular carcinoma and cholangiocellular carcinoma[J]. J Clin Hepatol,2017,33(7):1310-1315.(in Chinese)王春，邬昊，刘彦，等．Yes相关蛋白在肝细胞癌与胆管细胞癌中的表达特征及其与预后的关系[J]．临床肝胆病杂志，2017,33(7):1310-1315.

[15] YE HY,XU JW,CHEN L,et al. Expression and clinical significance of hsa-miRNA-200c in patients with liver metastasis of epithelial ovarian cancer[J]. Chin J Pract Gynecol Obstetr,2019,35(5):574-578.(in Chinese)叶海燕，徐嘉文，陈乐，等．hsa-miRNA-200c在肝转移型卵巢上皮性癌中的表达及其临床意义[J]．中国实用妇科与产科杂志，2019,35(5):574-578.

[16] LIU XY,HE YY,PENG C,et al. Mucin-3 and-4 expressions in hepatolithiasis-associated intrahepatic cholangiocarcinoma and their significance[J]. Chin J Gen Surg,2018,27(2):193-198.(in Chinese)刘鑫宇，贺彦宇，彭创，等．黏蛋白3和黏蛋白4在结石相关肝内胆管细胞癌中的表达及意义[J]．中国普通外科杂志，2018,27(2):193-198.

[17] ZHAO LF,CHENG WH,LEI D,et al. The relationship between DKK1 protein expression and lymph node invasion,and prognosis in patients with intrahepatic cholangiocarcinoma[J].Pract Oncol J,2017,31(3):228-233.(in Chinese)赵利锋，程伟华，雷达，等．DKK1蛋白表达与肝内胆管细胞癌患者淋巴结侵犯及其预后的相关性研究[J]．实用肿瘤学杂志，2017,31(3):228-233.

[18] ZHANG K,CHE S,SU Z,et al. CD90 promotes cell migration,viability and sphere-forming ability of hepatocellular carcinoma cells[J]. Int J Mol Med,2018,41(2):946-954.

[19] PENG R,HUANG XY,CAI JB,et al. Expression and clinical significance of TRIM44 and MMP9 in intrahepatic cholangiocarcinoma[J]. Chin J Clinl Med,2018,25(4):573-577.(in Chinese)彭睿，黄晓勇，蔡加彬，等．肝内胆管癌TRIM44、基质金属蛋白酶9蛋白的表达及临床意义[J]．中国临床医学，2018,25(4):573-577.

[20] YANG HY,LIU Y,DAI YZ,et al. Expression of CD90 and its clinical significance in different molecular subtypes of breast invasive ductal carcinoma[J]. Chin J Clin Exp Pathol,2017,33(3):245-249.(in Chinese)杨海玉，刘勇，戴艳枝，等．乳腺浸润性导管癌不同分子分型中CD90的表达及其意义[J]．临床与实验病理学杂志，2017,33(3):245-249.

[21] KANG Q,ZOU H,LIU LX,et al. Snail expression in intrahepatic cholangiocarcinoma and its clinical significance[J].Chin J Gen Surg,2017,26(2):199-204.(in Chinese)康强，邹浩，刘立鑫，等．Snail在肝内胆管癌中的表达及其临床意义[J]．中国普通外科杂志，2017,26(2):199-204.

施引文献

资源附件(0)

访问统计